(R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 97.0%, 10g

tert-Butyl 4-Formylbenzoate>98.0%(GC)1g

2-(2-Chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one hydrochloride, 98%, 25mg

2-Methyladamantan-2-yl methacrylate, 95.0%, 25g

N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine, 95.0%, 100g

3,4,5-Trimethoxyphenylboronic Acid (contains varying amounts of Anhydride)1g

2-Amino-7-bromoquinazolin-4(3H)-one, 95.0%, 100mg

2-Hydroxybenzyl alcohol, 95.0%, 1g

3-Cyclopentylacrylonitrile, 95%, 25g

(4,4'-Di-tert-butyl-2,2'-bipyridine-kappa~2~N~1~,N~1'~)[bis[3,5-difluoro-2-(5-methyl-2-pyridinyl-kappaN)phenyl-kappaC~1~]]iridium Hexafluorophosphate>90.0%(HPLC)1g

Tubos de ensayo, Base redonda, 4 ml, 1000 Unidad(es)

(2R,3S)-1-tert-Butoxycarbonyl-2-methyl-pyrrolidine-3-carboxylic acid, 98%, 100mg

N',N-Bis(salicylidene)-1,2-propanediamine, 97%, 100g